Home / Asia-Pacific / China / Intellectual Property
padlock hanging from turquoise painted wooden doors

Intellectual Property

In today’s knowledge economy, a large part of the value of your business is based on intangible assets and goodwill. Your intellectual property plays a key role in obtaining a competitive advantage. A cohesive IP strategy, including both commercialisation and enforcement, will ensure you get maximum value from your portfolio. With 150 specialist lawyers in more than 40 countries, we understand your business needs and have worked with some of the best-known brands, from banks to tech companies, pharmaceuticals and FMCG companies. This industry-specific approach can help you realise your commercial goals.

The right brands will win the hearts and minds of your customers. The right patents will prevent others exploiting your ideas or provide a substantial barrier to market access. Copyright, confidentiality and rights to designs also play a vital role. We focus on key sectors relevant to you such as lifesciences, automotive, manufacturing, consumer products, financial services and TMC. This means you get in-depth industry knowledge as well as legal expertise. If you are involved in a dispute, we can guide you through the litigation process, ensuring the best outcome in both domestic and international courts.

In China, we also have strategic collaborations with China Pharmaceutical University (CPU) and other leading academic institutions, enabling high quality technical analysis in a broad range of scientific disciplines and support from leading research professors.


Feed

01/06/2023
PRC Pub­lished the Guide to Ap­plic­a­tions for Re­cord-fil­ing of Stand­ard Con­tract...
The Cy­ber­space Ad­min­is­tra­tion of China ("CAC") pub­lished the first edi­tion of the Guide to Ap­plic­a­tions for Re­cord-fil­ing of Stand­ard Con­tract for Out­bound Per­son­al In­form­a­tion Trans­fers ("Guide") on...
Newsletter
27/04/2023
Top IP de­vel­op­ments and pre­dic­tions across Asia-Pa­cific
We look back at the top de­vel­op­ments over the last 12 months in In­tel­lec­tu­al Prop­erty (IP) and we look to the fu­ture by of­fer­ing our top pre­dic­tions for the com­ing year for busi­nesses op­er­at­ing across...
Law-Now Intellectual Property
26/04/2023
Are you ready for Chin­a's Stand­ard Con­tract for Out­bound Trans­fer of Per­son­al...
On 22 Feb­ru­ary 2023, the Cy­ber­space Ad­min­is­tra­tion of China (“CAC”) ad­op­ted the Meas­ures for the Stand­ard Con­tract for Out­bound Trans­fer of Per­son­al In­form­a­tion (“Meas­ures”). The Meas­ures will...
Newsletter
06/03/2023
CMS, China and CNBW held a we­bin­ar on what is new in Chinese law
On March 2, 2023, China Net­work Baden-Württem­berg (CNBW) and CMS, China jointly held a we­bin­ar on What is new in Chinese law – Top­ics which may con­cern you in 2023.Mr. Jochen Schultz, Man­aging Dir­ect­or...
News
21/02/2023
Case law on Trade Secrets in China
1. Re­quire­ment to un­der­take reas­on­able steps to keep the in­form­a­tion secret - art. 2(1)(c) Ac­cord­ing to Art­icle 9 of the AUCL, tak­ing reas­on­able steps to en­sure the con­fid­en­ti­al­ity is one pre­con­di­tion...
Expert Guide Commercial
Comparable
08/02/2023
APAC IP Up­date – Winter 2022/2023
Chin­aC­NIPA re­leased the an­nounce­ment of In­ter­im Meas­ures for Hand­ling Rel­ev­ant Ex­am­in­a­tion Op­er­a­tions for the Im­ple­ment­a­tion of the Amended Pat­ent Law­In or­der to en­sure the im­ple­ment­a­tion of the newly...
Law-Now Intellectual Property
19/12/2022
2023 – Top­ics that may Con­cern You
2022 has been a chal­len­ging year. In ad­di­tion to the con­tinu­ing im­pact of COV­ID-19 and the re­cent re­lax­a­tion meas­ures in China, the war in Ukraine has also brought im­pacts on so­ci­ety, polit­ics and busi­nesses.However...
Newsletter
16/12/2022
Com­par­at­ive Study: Pat­ent link­age sys­tems in APAC
Sum­mary In gen­er­al, a pat­ent link­age sys­tem provides for an early res­ol­u­tion of drug pat­ent dis­putes that links the drug mar­ket­ing ap­plic­a­tions to re­gistered pat­ents to re­solve pat­ent dis­putes and in­fringe­ment...
Law-Now Intellectual Property
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...
Law-Now Life Sciences & Healthcare
02/11/2022
APAC IP Up­date – Au­tumn 2022
China CNIPA re­leases China Pat­ent Sur­vey Re­port 2021 In Ju­ly 2022, the China Na­tion­al In­tel­lec­tu­al Prop­erty Ad­min­is­tratiion (CNIPA) re­leased the China Pat­ent Sur­vey Re­port 2021. The data in the re­port...
Law-Now Life Sciences & Healthcare
25/10/2022
Amend­ments to Vi­et­nam’s IP Laws to take ef­fect on 1 Jan 2023
On 16 June 2022, amend­ments to sev­er­al IP laws were of­fi­cially passed by the Na­tion­al As­sembly of Vi­et­nam to com­ply with Vi­et­nam’s ob­lig­a­tions un­der vari­ous treat­ies and to align Vi­et­nam laws more closely...
Law-Now Intellectual Property
23/09/2022
PRC Pub­lished the Guide to Ap­plic­a­tions for Se­cur­ity As­sess­ment of Out­bound...
The Cy­ber­space Ad­min­is­tra­tion of China ("CAC") re­cently pub­lished the first edi­tion of the Guide to Ap­plic­a­tions for Se­cur­ity As­sess­ment of Out­bound Data Trans­fers ("Guide"). It provides prac­tic­al guid­ance...
Law-Now Intellectual Property
Load more articles